ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Aktis Oncology Inc

Aktis Oncology Inc (AKTS)

31,76
0,87
(2,82%)
Fermé 03 Juillet 10:00PM
31,80
0,04
(0,13%)
Après les heures de négociation: 1:59AM

Aktis Oncology Inc (AKTS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
31,76
( 2,82% )
Prix Achat
23,18
Prix Vente
61,86
Volume échangé
723 725
30,04 Fourchette du Jour 31,965
0,0372 Plage de 52 semaines 34,1899
Cap du marché
Clôture Veille
30,89
Ouverture
31,00
Dernière Transaction
1
@
31.76
Dernière heure de transaction
Volume financier
US$ 22 195 082
VWAP
30,6678
Volume moyen (3 m)
US$ 294 328
Actions en circulation
55 277 447
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-6,14
Bénéfice par action (BPA)
-5,25
Chiffre d'affairess (LTM)
8,28M
Bénéfice net (LTM)
-67,07M

À propos de Aktis Oncology Inc

Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is... Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts. Show more

Secteur
Technology
Industrie
Hardware & Equipment
Siège social
Boston, United States
Fondé
2026
Aktis Oncology Inc est coté dans le secteur Technology de la NASDAQ avec le ticker AKTS. Le dernier cours de clôture d'Aktis Oncology était de US$30,89. Au cours de la dernière année, les actions de Aktis Oncology ont été négociées dans une fourchette de prix de US$ 0,0372 à US$ 34,1899.

Aktis Oncology compte actuellement 55 277 447 actions en circulation. La capitalisation boursière d'Aktis Oncology est de US$1,76 milliard. Aktis Oncology a un ratio cours/bénéfice (ratio PE) de -6.14.

AKTS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.866.2207357859529.934.189928.44587538630.80830885CS
412.262.372188139119.5634.189918.2549501626.66917212CS
1214.8888.151658767816.8834.189916.129439223.42597427CS
2631.722885276.3440860.037234.18990.037228540421.15030835CS
5231.722885276.3440860.037234.18990.037214099721.15030835CS
15628.6905.0632911393.1634.18990.03339643100.43274299CS
26020.88191.91176470610.8834.18990.03325878480.81168102CS

AKTS - Frequently Asked Questions (FAQ)

What is the current Aktis Oncology Inc share price?
The current share price of Aktis Oncology Inc is US$ 31,76
How many Aktis Oncology Inc shares are in issue?
Aktis Oncology Inc has 55 277 447 shares in issue
What is the market cap of Aktis Oncology Inc?
The market capitalisation of Aktis Oncology Inc is USD 1,76B
What is the 1 year trading range for Aktis Oncology Inc share price?
Aktis Oncology Inc has traded in the range of US$ 0,0372 to US$ 34,1899 during the past year
What is the PE ratio of Aktis Oncology Inc?
The price to earnings ratio of Aktis Oncology Inc is -6,14
What is the cash to sales ratio of Aktis Oncology Inc?
The cash to sales ratio of Aktis Oncology Inc is 215,25
What is the registered address of Aktis Oncology Inc?
The registered address for Aktis Oncology Inc is 17 Drydock Avenue, Boston, Massachusetts, 02210
What is the Aktis Oncology Inc website address?
The website address for Aktis Oncology Inc is www.aktisoncology.com
Which industry sector does Aktis Oncology Inc operate in?
Aktis Oncology Inc operates in the Hardware & Equipment sector

AKTS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock